Neonatal Medicine

  • 제18권2호
  • /
  • Pages.370-373
  • /
  • 2011
  • /
  • 2287-9412(pISSN)
  • /
  • 2287-9803(eISSN)
대한신생아학회 (The Korean Society of Neonatology)
권호 표지
DOI QR코드

DOI QR Code

Novel Compound Heterozygote Mutations of the SLC25A13 Gene in an Infant with Neonatal-onset Type II Citrullinemia Detected by Newborn Mass Screening

  • Lim, Ho-Seop (Department of Pediatrics, College of Medicine, Soonchunhyang University) ;
  • Kim, Ho (Department of Pediatrics, College of Medicine, Soonchunhyang University) ;
  • Kim, Sung-Shin (Department of Pediatrics, College of Medicine, Soonchunhyang University) ;
  • Kim, Gu-Hwan (Department of Pediatrics, Medical Genetics Clinic and Laboratory) ;
  • Yoo, Han-Wook (Department of Pediatrics, Medical Genetics Clinic and Laboratory) ;
  • Shin, Young-Lim (Department of Pediatrics, College of Medicine, Soonchunhyang University)
  • 발행 : 2011.11.30
⟨ 이전 논문 다음 논문 ⟩

초록

Citrin deficiency는 염색체 7q21.3의 SLC25A13 유전자 돌연변이에 의해 발생하는 상염색체 열성질환으로 neonatal-onset type II citrullinemia (CTLN2) 및 adult-onset CTLN2로 분류된다. 생후 16일된 여아가 신생아 대사 검사에서 citrullinemia (CTLN)가 의심되었고 혈중 아미노산 분석에서 CTLN 및 고암모니아혈증을 보였고, SLC25A13 유전자 분석 결과 c.221C>T in exon4 and c.1645C in exon16 (p.[Ser74Phe]+[Gln549X]) 의 새로운 돌연변이가 발견되어 neonatal-onset CTLN2로 진단되었다. 저자들은 신생아 대사 검사에서 citrullinemia를 보이는 영아들에서 확진을 위한 유전자 검사 및 혈중 아미노산 분석이 필요하다고 생각한다.

Citrin deficiency caused by the SLC25A13 gene mutations is associated with both neonatal-onset type II citrullinemia (CTLN2), also known as neonatal intrahepatic cholestasis caused by citrin deficiency and adult-onset CTLN2. Neonatal-onset CTLN2 is an autosomal recessive disorder characterized by poor growth, intrahepatic cholestasis, and increased serum citrulline. A 16-days old infant with hyperammonemia was referred for evaluation of increased plasma citrulline diagnosed using tandem mass spectrometry. Blood amino acid analysis showed significant elevation of citrulline. Mild elevation in serum galactose levels had been found. DNA analysis of the SLC25A13 gene in this patient showed two novel compound heterozygous mutations, c.221C>T in exon4 and c.1645C in exon16 (p.[Ser74Phe]+[Gln549X]). We suggest that infants with a high serum citrulline level on a tandem mass screening test are candidates for gene analysis and blood amino acid analysis for neonatal-onset CTLN2.

키워드

참고문헌

  1. Kakinoki H, Kobayashi K, Terazono H, Nagata Y, Saheki T. Mutations and DNA diagnoses of classical citrullinemia. Hum Mutat 1997;9:250-9. https://doi.org/10.1002/(SICI)1098-1004(1997)9:3<250::AID-HUMU6>3.0.CO;2-B
  2. Ohura T, Kobayashi K, Tazawa Y, Nishi I, Abukawa D, Sakamoto O, et al. Neonatal presentation of adult-onset type II citrullinemia. Hum Genet 2001;108:87-90. https://doi.org/10.1007/s004390000448
  3. Kobayashi K, Shaheen N, Kumashiro R, Tanikawa K, O'Brien WE, Beaudet AL, et al. A search for the primary abnormality in adultonset type II citrullinemia. Am J Hum Genet 1993;53:1024-30.
  4. Lee BH, Jin HY, Kim GH, Choi JH, Yoo HW. Nonalcoholic fatty liver disease in 2 siblings with adult-onset type II citrullinemia. J Pediatr Gastroenterol Nutr 2010;50:682-5. https://doi.org/10.1097/MPG.0b013e3181d67fbf
  5. Lin JT, Hsiao KJ, Chen CY, Wu CC, Lin SJ, Chou YY, et al. High resolution melting analysis for the detection of SLC25A13 gene mutations in Taiwan. Clin Chim Acta 2011;412:460-5. https://doi.org/10.1016/j.cca.2010.11.027
  6. Saheki T, Kobayashi K, Iijima M, Horiuchi M, Begum L, Jalil MA, et al. Adult-onset type II citrullinemia and idiopathic neonatal hepatitis caused by citrin deficiency: involvement of the aspartate glutamate carrier for urea synthesis and maintenance of the urea cycle. Mol Genet Metab 2004;81 Suppl 1:S20-6.
  7. Saheki T, Inoue K, Tushima A, Mutoh K, Kobayashi K. Citrin deficiency deficiency and current treatment concepts. Mol Genet Metab 2010;100 Suppl 1:S59-64.
  8. Lu YB, Kobayashi K, Ushikai M, Tabata A, Iijima M, Li MX, et al. Frequency and distribution in East Asia of 12 mutations identified in the SLC25A13 gene of Japanese patients with citrin deficiency. J Hum Genet 2005;50:338-46. https://doi.org/10.1007/s10038-005-0262-8
  9. Ko JM, Kim GH, Kim JH, Kim JY, Choi JH, Ushikai M, et al. Six cases of citrin deficiency in Korea. Int J Mol Med 2007;20:809-15.
  10. Tokuhara D, Iijima M, Tamamori A, Ohura T, Takaya J, Maisawa S, et al. Novel diagnostic approach to citrin deficiency: analysis of citrin protein in lymphocytes. Mol Genet Metab 2007;90:30-6. https://doi.org/10.1016/j.ymgme.2006.09.009
  11. Kobayashi K, Saheki T. Citrin deficiency. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews. Seattle (WA): University of Washington, 2005.
  12. Tamamori A, Fujimoto A, Okano Y, Kobayashi K, Saheki T, Tagami Y, et al. Effects of citrin deficiency in the perinatal period: feasibility of newborn mass screening for citrin deficiency. Pediatr Res 2004;56:608-14. https://doi.org/10.1203/01.PDR.0000139713.64264.BC
  13. Kobayashi K, Sinasac DS, Iijima M, Boright AP, Begum L, Lee JR, et al. The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nat Genet 1999;22:159-63. https://doi.org/10.1038/9667
  14. Saheki T, Kobayashi K, Terashi M, Ohura T, Yanagawa Y, Okano Y, et al. Reduced carbohydrate intake in citrin-deficient subjects. J Inherit Metab Dis 2008;31:386-94. https://doi.org/10.1007/s10545-008-0752-x

피인용 문헌

  1. Study of 17-α-hydroxy Progesterone in Preterm Infants vol.19, pp.2, 2011, https://doi.org/10.5385/jksn.2012.19.2.77